— Know what they know.
Not Investment Advice

FPHAX

Fidelity Select Pharmaceuticals
1W: -3.1% 1M: -4.6% 3M: -3.6% YTD: +9.7% 1Y: +20.3% 3Y: +61.9% 5Y: +77.4%
$33.86
-0.06 (-0.18%)
 
Weekly Expected Move ±2.5%
$32 $33 $34 $35 $36
ETF NASDAQ · AUM $1.2B

Portfolio Health Summary

IS Overall Score
57.5
★★★★★
Altman Z-Score
854.00
Safe
Weight Coverage
97%
of portfolio analyzed
Holdings Matched
42
with fundamental data

InsiderStreet Scorecard

★★★★★ 57.5
Profitability
66.7
Balance Sheet
54.5
Earnings Quality
57.9
Growth
59.9
Value
46.0
Momentum
74.0
Safety
83.9

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
854.00
Safe Zone (>2.99)
Piotroski F-Score
6.1 / 9
Moderate
Beneish M-Score
-1.77
Possible Manipulator
Credit Score
—
Earnings Quality
57.9 / 100

Portfolio Valuation

P/E
27.46x
P/B
11.71x
P/S
6.80x
EV/EBITDA
20.96x
EV/Revenue
9.20x
P/FCF
30.46x
P/OCF
22.19x
PEG
1.03x
Earnings Yield
3.64%
FCF Yield
3.28%
OCF Yield
4.51%
Median P/E
-6.12x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +20.6%
Net Income +43.1%
EPS +46.0%
FCF +72.2%
EBITDA +60.9%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +20.4%
Rev CAGR 5Y +19.1%
EPS CAGR 3Y +26.7%
EPS CAGR 5Y +21.6%
FCF CAGR 3Y +37.9%
FCF CAGR 5Y +21.1%
EBITDA CAGR 3Y +30.6%
EBITDA CAGR 5Y +19.2%
Payout Ratio
49.86%
Buyback Yield
0.36%
Dividend Yield
1.32%
Total Shareholder Return
-1.42%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$33.92
Median 1Y
$37.97
5th Pctile
$28.00
95th Pctile
$51.93
Ann. Volatility
19.5%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 27.46
Portfolio P/B 11.71
Portfolio P/S 6.80
EV/EBITDA 20.96
EV/Revenue 9.20
P/FCF 30.46
P/OCF 22.19
PEG 1.03
Earnings Yield 3.64%
FCF Yield 3.28%
OCF Yield 4.51%
Median P/E -6.12
Profitability & Returns (9)
MetricValue
Gross Margin 78.79%
Operating Margin 36.03%
Net Margin 23.57%
FCF Margin 22.21%
ROE 45.49%
ROA 13.98%
ROIC 27.00%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 1.08
Debt/Assets 0.34
Net Debt/EBITDA 1.10
Interest Coverage 24.09
Current Ratio 1.24
Quick Ratio 0.92
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 20.60%
Net Income Growth 43.08%
EPS Growth 45.98%
FCF Growth 72.17%
EBITDA Growth 60.93%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 20.38%
Revenue CAGR 5Y 19.11%
Revenue CAGR 10Y —
EPS CAGR 3Y 26.65%
EPS CAGR 5Y 21.63%
EPS CAGR 10Y —
FCF CAGR 3Y 37.88%
FCF CAGR 5Y 21.05%
FCF CAGR 10Y —
EBITDA CAGR 3Y 30.59%
EBITDA CAGR 5Y 19.23%
EBITDA CAGR 10Y —
Net Income CAGR 3Y 25.64%
Net Income CAGR 5Y 21.83%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 57.5
IS Profitability 66.7
IS Balance Sheet 54.5
IS Earnings Quality 57.9
IS Growth 59.9
IS Value 46.0
IS Momentum 74.0
IS Safety 83.9
IS Quality 69.1
Altman Z-Score 854.00
Piotroski F-Score 6.11
Beneish M-Score -1.77
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 1.32%
Payout Ratio 49.86%
Buyback Yield 0.36%
Total Shareholder Return -1.42%
Growth Stability (4)
MetricValue
Revenue Stability 0.662
Earnings Stability 0.420
Earnings Persistence 0.655
Margin Stability 0.837
Medians (3)
MetricValue
Median P/E -6.12
Median P/B 4.26
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 97.45%
Holdings Matched 42
Total Holdings 44

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms